An amino acid mixture improves glucose tolerance and lowers insulin resistance in the obese Zucker rat

被引:0
作者
Jeffrey R. Bernard
Yi-Hung Liao
Zhenping Ding
Daisuke Hara
Maximilian Kleinert
Jeffrey L. Nelson
John L. Ivy
机构
[1] Saint Mary’s College of California,Department of Biology
[2] University of Texas at Austin,Exercise Physiology and Metabolism Laboratory, Department of Kinesiology and Health Education
[3] Abbott Nutrition,Department of Exercise and Health Science
[4] Abbott Laboratories,undefined
[5] National Taipei University of Nursing and Health Sciences,undefined
来源
Amino Acids | 2013年 / 45卷
关键词
Oral glucose tolerance test; Isoleucine; Leucine; Akt substrate of 160 kDa (AS160); Skeletal muscle;
D O I
暂无
中图分类号
学科分类号
摘要
The purpose of this investigation was to test an amino acid mixture on glucose tolerance in obese Zucker rats [experiment (Exp)-1] and determine whether differences in blood glucose were associated with alterations in muscle glucose uptake [experiment (Exp)-2]. Exp-1 rats were gavaged with either carbohydrate (OB-CHO), carbohydrate plus amino acid mixture (OB-AA-1), carbohydrate plus amino acid mixture with increased leucine concentration (OB-AA-2) or water (OB-PLA). The glucose response in OB-AA-1 and OB-AA-2 were similar, and both were lower compared to OB-CHO. This effect of the amino acid mixtures did not appear to be solely attributable to an increase in plasma insulin. Rats in Exp-2 were gavaged with carbohydrate (OB-CHO), carbohydrate plus amino acid mixture (OB-AA-1) or water (OB-PLA). Lean Zuckers were gavaged with carbohydrate (LN-CHO). Fifteen minutes after gavage, a radiolabeled glucose analog was infused through a catheter previously implanted in the right jugular vein. Blood glucose was significantly lower in OB-AA-1 compared to OB-CHO while the insulin responses were similar. Glucose uptake was greater in OB-AA-1 compared with OB-CHO, and similar to that in LN-CHO in red gastrocnemius muscle (5.15 ± 0.29, 3.8 ± 0.27, 5.18 ± 0.34 µmol/100 g/min, respectively). Western blot analysis showed that Akt substrate of 160 kDa (AS160) phosphorylation was enhanced for OB-AA-1 and LN-CHO compared to OB-CHO. These findings suggest that an amino acid mixture improves glucose tolerance in an insulin resistant model and that these improvements are associated with an increase in skeletal muscle glucose uptake possibly due to improved intracellular signaling.
引用
收藏
页码:191 / 203
页数:12
相关论文
共 193 条
[1]  
Atherton PJ(2010)Distinct anabolic signaling responses to amino acids in C2C12 skeletal muscle cells Amino Acids 38 1533-1539
[2]  
Smith K(1982)An improved jugular vein cannulation procedure and cannula storage apparatus Physiol Behav 29 949-951
[3]  
Etheridge T(1992)Muscle glucose transport, GLTU-4 content, and degree of exercise training in obese Zucker rats Am J Physiol 263 E1010-E1015
[4]  
Rankin D(2010)Increased levels of peroxisome proliferators-activated receptor gamma, coactivator 1 alpha (PGC-1α) improve lipid utilization, insulin signaling and glucose transport in skeletal muscle of lean and insulin-resistance obese Zucker rats Diabetologia 53 2008-2019
[5]  
Rennie MJ(2011)An amino acid mixture improves glucose tolerance and insulin signaling in Sprague Dawley rats Am J Physiol Endocrinol Metab 300 E752-E760
[6]  
Axelson JF(2012)An amino acid mixture is essential to optimize insulin-stimulated glucose uptake and GLUT4 translocation in perfused rodent hindlimb muscle J Appl Physiol 113 97-104
[7]  
Bruot BC(1993)Effects of exercise training on muscle GLUT-4 protein content and translocation in obese Zucker rats Am J Physiol 265 E419-E427
[8]  
Banks EA(2002)Exercise training improves muscle insulin resistance but not insulin receptor signaling in obese Zucker rats J Appl Physiol 92 736-744
[9]  
Brozinick JT(1980)Insulin resistance in soleus muscle from Zucker obese rats. Involvement of several defective sites Biochem J 186 525-534
[10]  
Yaspelkis BB(1981)The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization Diabetes 30 1000-1007